Exchange: NYSE·Updated 07:30 PM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 05

Estimated EPS

$0.27

Reported EPS

$0.34

Surprise

+26.3%

Estimated Rev

$1.31B

Reported Rev

$1.37B

Surprise

+4.23%

• Reported GAAP EPS of $0.11 up 450.00% YoY • Reported revenue of $1.37B up 10.23% YoY • Elanco Animal Health raised full year 2026 revenue guidance to $5.09 billion to $5.14 billion, adjusted EBITDA to $1.01 billion to $1.035 billion, and adjusted EPS to $1.10 to $1.16.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.21
--
--
N/A
Q2 '26
$0.27
$0.34
26.30%
BEAT
Q1 '26
$0.35
$0.40
15.75%
BEAT
Q4 '25
$0.11
$0.13
14.58%
BEAT
Q3 '25
$0.13
$0.19
46.16%
BEAT

Advertisement|Remove ads.